HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mauro Giacca Selected Research

human VEGFB protein

6/2010Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy.
5/2010Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mauro Giacca Research Topics

Disease

18Neoplasms (Cancer)
01/2021 - 01/2003
12Myocardial Infarction
10/2022 - 05/2010
12Infections
01/2022 - 01/2004
11Inflammation (Inflammations)
01/2022 - 09/2005
9Ischemia
10/2022 - 09/2003
9Heart Failure
10/2021 - 06/2010
7Fibrosis (Cirrhosis)
10/2022 - 05/2010
6Hypertrophy
12/2021 - 05/2010
6Cardiomyopathies (Cardiomyopathy)
01/2020 - 05/2011
4COVID-19
01/2022 - 11/2020
4Insulin Resistance
01/2022 - 12/2012
4Necrosis
01/2021 - 10/2005
4Pathologic Neovascularization
01/2018 - 11/2007
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2017
3Hyperplasia
10/2021 - 02/2003
3Obesity
11/2020 - 12/2012
3Mitochondrial Diseases (Mitochondrial Disease)
11/2020 - 12/2017
3Salmonella Infections (Salmonellosis)
01/2020 - 03/2011
3Cardiomegaly (Heart Hypertrophy)
09/2013 - 06/2010
2Cicatrix (Scar)
10/2022 - 01/2019
2Disease Progression
03/2019 - 11/2014
2Vesicular Stomatitis
09/2018 - 11/2009
2Macular Degeneration (Age-Related Maculopathy)
01/2018 - 02/2011
2Retinal Neovascularization
01/2018 - 02/2011
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2017 - 11/2007
2Stomatitis
09/2016 - 12/2013
2Carcinogenesis
09/2016 - 11/2009
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
07/2015 - 06/2010
2Infarction (Infarctions)
06/2015 - 08/2003
2Virus Diseases (Viral Diseases)
05/2015 - 02/2005
2Heart Diseases (Heart Disease)
09/2013 - 05/2013
2Choroidal Neovascularization
12/2012 - 02/2011
2Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2012 - 03/2009
2Scrapie
09/2012 - 03/2009
2Hypoxia (Hypoxemia)
05/2012 - 05/2010
2Wounds and Injuries (Trauma)
06/2008 - 04/2003
2Neoplasm Metastasis (Metastasis)
11/2007 - 01/2004
2Neointima
09/2005 - 06/2004
1Myocarditis (Carditis)
01/2022
1Kidney Diseases (Kidney Disease)
01/2022
1Huntington Disease (Huntington's Disease)
11/2021

Drug/Important Bio-Agent (IBA)

15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013 - 04/2003
14MicroRNAs (MicroRNA)IBA
10/2021 - 03/2011
12Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2002
6GhrelinIBA
12/2017 - 12/2012
5CytokinesIBA
01/2022 - 09/2013
5Insulin (Novolin)FDA Link
11/2020 - 06/2011
4CollagenIBA
10/2022 - 06/2004
4Pharmaceutical PreparationsIBA
01/2022 - 01/2004
4RNA (Ribonucleic Acid)IBA
11/2021 - 03/2011
4EnzymesIBA
03/2021 - 04/2003
4IntegrasesIBA
01/2019 - 03/2010
4Vascular Endothelial Growth Factor BIBA
07/2015 - 05/2010
4Streptozocin (Streptozotocin)FDA Link
01/2012 - 10/2006
3AntibodiesIBA
10/2022 - 03/2008
3Peptides (Polypeptides)IBA
01/2021 - 04/2005
3Biomarkers (Surrogate Marker)IBA
01/2019 - 08/2008
3Semaphorin-3AIBA
01/2018 - 11/2009
3Complementary DNA (cDNA)IBA
11/2014 - 01/2004
3Messenger RNA (mRNA)IBA
06/2008 - 04/2003
2LipidsIBA
01/2022 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2004
2Angiogenesis InhibitorsIBA
01/2021 - 11/2009
2Glycoproteins (Glycoprotein)IBA
09/2018 - 11/2009
2Semaphorins (Semaphorin)IBA
01/2018 - 11/2009
2Adenosine Triphosphatases (ATPase)IBA
07/2017 - 05/2011
2Hormones (Hormone)IBA
01/2017 - 01/2016
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
07/2013 - 05/2011
2Neuropilin-1IBA
12/2012 - 05/2010
2PrionsIBA
09/2012 - 03/2009
2human VEGFB proteinIBA
06/2010 - 05/2010
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
05/2010 - 06/2008
2LigandsIBA
05/2010 - 10/2006
2NitratesIBA
06/2008 - 04/2003
2Thymidine KinaseIBA
12/2005 - 01/2003
2Matrix Metalloproteinases (MMPs)IBA
06/2004 - 01/2004
2Catalytic RNA (Ribozymes)IBA
01/2004 - 01/2002
2NF-kappa B (NF-kB)IBA
08/2003 - 02/2003
2NF-KappaB Inhibitor alphaIBA
08/2003 - 02/2003
1Therapeutic UsesIBA
10/2022
1Bone Morphogenetic Protein 1IBA
10/2022
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
10/2022
1Protein Isoforms (Isoforms)IBA
10/2022
1Monoclonal AntibodiesIBA
10/2022
1Interleukin-9 (Interleukin 9)IBA
01/2022
1AnidulafunginFDA Link
01/2022
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2022
1Sirolimus (Rapamycin)FDA Link
12/2021
1ProteomeIBA
12/2021
1Mechanistic Target of Rapamycin Complex 1IBA
12/2021
1CholesterolIBA
11/2021
1Dopamine Receptors (Dopamine Receptor)IBA
11/2021
1Viral AntigensIBA
11/2021

Therapy/Procedure

20Therapeutics
01/2022 - 09/2003
4Drug Therapy (Chemotherapy)
01/2021 - 11/2007
3Lasers (Laser)
09/2016 - 02/2011
2Heart Transplantation (Grafting, Heart)
01/2020 - 03/2019
2Laser Therapy (Surgery, Laser)
09/2016 - 12/2013
2Intramuscular Injections
01/2013 - 01/2007
1Aftercare (After-Treatment)
01/2022